Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Windlas Biotech Limited
WINDLAS | NSE
814.15
INR3.00
0.37%
WINDLAS | NSE
Loading StockChartView...
About Windlas Biotech Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
05/06/2026
Close
814.15
Open
805.20
High
818.00
Low
793.50
Windlas Biotech Limited contract development and manufacturing organization (CDMO) manufactures and trades in pharmaceutical products in India. It offers CDMO services including product discovery product development licensing and commercial manufacturing of generic products. The company also provides manufactures various domestic trade generics and over-the-counter brands which include nutraceutical and health supplement products through the online and offline channels. In addition it manufactures pills capsules pouches sachets and liquid bottles; and generic products portfolio comprises fixed dosage combinations fixed dosage plus modified release combinations customized generics and chewable or dispersible. It exports its products primarily to Cambodia Ivory Coast the Philippines Thailand Vietnam Myanmar and Sri Lanka. The company was incorporated in 2001 and is based in Gurugram India.
View LessWINDLAS | NSE
Risk
34.0
Sharpe
-0.53
Luna's Score
61/100
Recommendation
Hold
Luna says (WINDLAS | NSE)
What's Working
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
30.1%1 month
34.0%3 months
34.5%6 months
35.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
35.85
Fwd. PE
-
Price to book
4.72
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
21.00
Ent. to rev.
3.06
PEG
-
Other Fundamentals
EBITDA
795.44M
MarketCap
17.07B
MarketCap(USD)
179.85M
Div. yield
0.54
Op. margin
8.38
Erngs. growth
11.20
Rev. growth
21.00
Ret. on equity
13.66
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
100.55
Range1M
138.35
Range3M
201.40
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.09
Price X volume
60.39M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 21.00 | 24.85 | Par |
| Ent. to Revenue | 3.06 | 11.40 | Cheaper |
| PE Ratio | 35.85 | 51.36 | Cheaper |
| Price to Book | 4.72 | 6.83 | Cheaper |
| Dividend Yield | 0.54 | 0.52 | Par |
| Std. Deviation (3M) | 34.49 | 42.17 | Par |
| Debt to Equity | 0.01 | 0.35 | Cheaper |
| Debt to Assets | 0.01 | 0.17 | Cheaper |
| Market Cap | 17.07B | 290.82B | Emerging |
